Lewis Teperman, M.D., Dilip Moonka, M.D., Anthony Sebastian, M.D., Linda Sher, M.D., Paul Marotta, M.D., Christopher Marsh, M.D., Baburao Koneru, M.D., John Goss, M.D., and John P. Roberts, M.D., received funding from Roche (Nutley, NJ) for the conduct of this study. Sher and Roberts currently are receiving research funding from Novartis. Dennis Preston, Pharm.D., currently is an employee of Genentech, which was acquired by Roche after the study was completed.
Calcineurin Inhibitor–Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial
Article first published online: 25 JUN 2013
© 2013 American Association for the Study of Liver Diseases
Volume 19, Issue 7, pages 675–689, July 2013
How to Cite
Teperman, L., Moonka, D., Sebastian, A., Sher, L., Marotta, P., Marsh, C., Koneru, B., Goss, J., Preston, D., Roberts, J. P. and Spare-the-Nephron Trial Liver Transplantation Study Group (2013), Calcineurin Inhibitor–Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial. Liver Transpl, 19: 675–689. doi: 10.1002/lt.23658
The study sponsor, Roche, provided financial support for this research and contributed to the study design, analysis, and interpretation; and the development of the article.
The members of the Spare-the-Nephron Trial Liver Transplantation Study Group are listed in the Supporting Information.
- Issue published online: 25 JUN 2013
- Article first published online: 25 JUN 2013
- Accepted manuscript online: 15 JUN 2013 02:24AM EST
- Manuscript Accepted: 8 APR 2013
- Manuscript Received: 30 DEC 2012
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.